Prognostic significance of myocardial enzyme release after coronary interventions

D Kelly1, R Arora

  • 1Department of Medicine, Columbia Presbyterian Medical Center, New York, NY 10032, USA.

Insights

Mild elevations in cardiac enzymes after procedures increase risks of heart attack and death. These risks must be weighed against alternative treatments and continued medical management for patients undergoing percutaneous revascularization.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Periprocedural myocardial injury, indicated by elevated creatine kinase (CK) and CK-myocardial band (MB), is a recognized complication.
  • The clinical significance of mild to moderate enzyme elevations following percutaneous revascularization remains incompletely understood.

Purpose of the Study:

  • To evaluate the prognostic implications of periprocedural creatine kinase (CK) and CK-myocardial band (MB) elevations.
  • To inform risk-benefit assessments for percutaneous revascularization versus alternative management strategies.

Main Methods:

  • Analysis of clinical data correlating periprocedural enzyme levels with subsequent cardiac events.
  • Review of existing literature on periprocedural myocardial injury and long-term outcomes.

Main Results:

  • Mild to moderate elevations in CK and CK-MB post-procedure are associated with increased risk of subsequent myocardial infarction.
  • These enzyme elevations correlate with higher mortality rates.

Conclusions:

  • Periprocedural enzyme elevations are significant indicators of future cardiac events and mortality.
  • Clinical decisions regarding percutaneous revascularization must consider these risks alongside alternative treatments and ongoing medical management.
  • Further prospective studies are needed to fully elucidate the long-term prognosis associated with periprocedural enzyme elevations.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...